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Badqround: The immunoglobulin framework has been mutagenized to engineer 
recombinant libraries of proteins as potential diagnostics and novel catalysts, 
although the often shallow binding cleft may limit the utility of this framework for 
binding diverse small organic molecules. By contrast, the glutathione S- 
transferase (GST) family of enzymes contains a deep binding cleft, which has 
evolved to accommodate a broad range of hydrophobic xenobiotics. We set out 
to determine whether GST molecules with novel ligand-binding characteristics 
could be produced by random mutagenesis of segments of the binding cleft. 
Results: We have identified two ligand-recognition segments (LRSs) in human 
GST Pl, which are near the active site in the folded protein, but have 
characteristics indicating that the integrity of their sequence is not essential for 
the overall structure or activity of the protein. Libraries of GST Pl -derived 
proteins were produced by substituting randomized sequences for an LRS or 
inserting random sequences into an LRS. The recombinant proteins in the 
libraries, collectively designated as ‘glubodies: generally retain enzymatic activity 
but differ markedly both from each other and from the parent enzyme in 
sensitivity to inhibition by diverse small organic compounds. In some instances, a 
glubody is inhibited by completely novel structures. 
Conclusions: We have shown that a non-antibody framework can be used to 
create large libraries of proteins with a wide range of binding specificities for 
small organic molecules. The glubodies provide a rich source of data for 
correlating the structural and functional features of proteins relevant to ligand 
binding. The criteria applied for identifying an LRS in GST Pl are generally 
applicable to other protein frameworks. 
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Introduction 
Although immunoglobulins function primarily by recog- 
nizing foreign protein and peptide structures [l], they can 
also bind to carbohydrates and other small molecules [‘Z]. 
Antisera, hybridomas, and a variety of recombinant 
antibodies [3] have thus been exploited to produce 
diagnostic reagents [4] and novel catalysts [5]. There are 
other families of protective proteins, which have evolved 
in parallel with the immunoglobulins and function 
primarily in elimination of both exogenous poisons and 
toxic metabolic byproducts of oxidative metabolism. 
Several enzymes can be included in this category; each 
enzyme manifests a broad spectrum of affinities for 
chemically diverse compounds, in contrast to mature 
antibodies, which bind a particular target with high 
affinity [6]. The glutathione S-transferase (GST) family of 
enzymes are among the proteins that can recognize the 
widest range of chemicals [7]. In humans, the GST family 
comprises at least a dozen cytosolic enzymes. They 
catalyze the conjugation of the tripeptide glutathione 
(GSH) to a broad range of hydrophobic electrophiles of 
both endogenous and exogenous origin, thus eliminating 
the potentially destructive electrophilic moieties. GSTs 
seem to have evolved a protein framework optimal for 
binding small organic molecules of the type often used as 
drugs, and indeed several drugs are known to be 
metabolized by GSTs. 
Mutagenesis has been extensively used to probe protein 
structure and function; in general, these studies have 
focused on particular residues or short segments within 
the amino-acid sequence. A recent study with GST 
homodimers has focused on Cys47; mutation of this 
residue can induce positive cooperativity in ligand 
binding by the GST subunits [8]. New techniques have 
been developed for making and screening large numbers 
of mutants containing short gene segments that have been 
nearly exhaustively replaced with random sequences. 
360 Chemistry & Biology 1996, Vol3 No 5 
These studies often concentrate on establishing a correl- 
ation between protein structure and the catalytic activity 
using a particular substrate. For example, libraries of 
mutagenized B-lactamase [9] and herpes thymidine kinase 
[lo,1 l] have been selected in Eschetichia cofi for the ability 
to mediate growth in ampicillin or suboptimal conc- 
entrations of thymidine, respectively. Mutant GST 
libraries have been screened for the ability to metabolize 
particular selective agents. In one case, mutants were 
isolated with increased catalytic activity toward merchlor- 
ethamine, an electrophilic nitrogen mustard [12]; in 
another case, phage display was used to generate mutant 
GSTs with altered specificities for specific glutathione 
(GSH) derivatives [13]. Although such studies provide 
information about binding of the enzyme to a particular 
agent, the selection techniques provide few insights into 
the range of structures to which the protein framework 
can be adapted by focused mutagenesis. Since natural 
GSTs display broad specificity in ligand binding, and the 
framework is amenable to mutagenesis, this protein 
provides an appropriate system for examining issues of 
plasticity in ligand binding. 
The GST binding pocket has been subdivided 
phenomenologically into a GSH-binding domain called 
the G-site, and an H-site where the hydrophobic 
substrates are bound prior to being conjugated to GSH 
[14]. The dimeric human Pl-1 isoform (a member of the 
Pi (P) class of GSTs) is one of the best characterized 
enzymes of the GSTs isolated from a wide range of plants 
and animals. GST Pl-1 has been cloned [15], and the 
crystal structure of the homodimer has been determined 
with a bound ligand [16]. The structure revealed that 
some portions of the H-site in this enzyme are not critical 
to the overall domain fold. The architecture of this 
enzyme is thus more suitable for the directed 
mutagenesis studies reported here than the Alpha (A) 
class of GST, which has been used previously to study 
altered substrate specificity [l&13]. The amino-acid 
segments that constitute the binding site in the A class 
are integral to the protein structure. 
Our analysis of published GST structures identified two 
regions near the active site that appear to be suitable for 
generating novel binding proteins. These ligand recog- 
nition segments (LRSs) are largely solvent exposed, 
show high mobility as measured by crystallographic 
temperature factors or molecular dynamics simulations, 
lack obvious importance for the structural integrity of the 
enzyme or the proposed catalytic mechanism, and 
participate in substrate recognition. Thus, an LRS is 
analogous to the somewhat larger CDR3 hypervariable 
loop in antibodies, which is thought not to contribute to 
the structural integrity of the antibody, but to be the 
most important structural segment contributing to 
antigen specificity [ 171. 
Two general classes of randomized libraries can in 
principle be generated: one in which the variants have an 
existing region replaced with a randomized sequence, or 
one with variants containing an insert of randomized 
sequence. Here we generate both types of libraries. Three 
LRS variant libraries of homodimeric GST Pl-1 were 
constructed by PCR mutagenesis. The resulting proteins, 
designated glubodies, are largely still catalytically active as 
glutathione S-transferases, confirming that the segments 
are dispensable for catalytic activity. Significant alterations 
in inhibitor potencies and selectivity are found among 
active variants, however, indicating the potential of LRS 
mutagenesis within the GST framework for generating 
proteins with varied ligand binding properties. 
Results and discussion 
Glubody design 
Structural analysis of GST isozymes using Insight II 
(Biosym Technologies, San Diego, CA) provided the 
rationale for the development of a diversified set of glu- 
bodies. Two crystal structures were available: GST Pl-1 
from human placenta in a complex with S-hexyl gluta- 
thione refined at 2.8 A resolution [ 161 and rat Mu (M) class 
GST 3-3 determined at 2.2 A resolution in a complex with 
glutathione (Brookhaven Data Bank code: IGST) [18]. In 
addition, the structures of three human M-class isozymes, 
generated by homology modeling [ 191, were analyzed. 
Because the structure of the enzyme has now been solved 
in the presence of a bound GSH conjugate, the topological 
elements involved in GSH and substrate recognition can 
be identified. The G-site contains the residues directly 
involved in GSH binding and activation. Tyr7 at this site 
has been implicated in formation of the thiolate species, 
which is thought to initiate formation of the glutathione 
conjugate. In classical protein structure-activity studies, 
mutations in Tyr7 significantly reduce the catalytic 
efficiency [ZO]. Three non-adjacent structural elements 
with significant flexibility relative to each other form the 
H-site: the Bl-al loop (residues 8-15); the carboxyl 
terminus (residues 201-210); and the a2 helix (residues 
36-44), which also forms part of the G-site [16]. Equivalent 
H-site elements occur in both P- and M-class isozymes. 
We aimed to expand the repertoire of ligands recognized 
by GST recognition, while minimizing structural changes 
(as monitored by preservation of enzymatic activity). In 
principle, variation of any H-site residues could alter ligand 
binding. The goal of maintaining the enzyme’s structural 
and functional integrity, however, merits a more thorough 
analysis of these three segments. 
The first potential LRS (residues 8-15) borders Tyr7, a 
residue known to be required for catalytic activity. 
Moreover, the direct interactions of residues 8-15 with 
neighboring residues that in turn interact with numerous 
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Figure 1 
Glubody replacement loops. The backbone of dimeric human GST 
Pl-1 is oriented to display the LRSs randomized by PCR 
mutagenesis (shown in black); the ball and stick figure molecule (in 
dark gray) that is docked into the active site is S-hexyl glutathione. 
The view shown here is down the molecular two-fold axis and into the 
ligand-binding site. 
non-contiguous residues indicates that the pl-ol segment 
is important for maintaining the integrity of domain 
folding. Randomization of residues 8-15 could thus cause 
a cascade of structural changes ultimately affecting the 
catalytic function. In contrast, the (-wZ helix and the 
carboxyl terminus, which also form part of the H-site 
(highlighted in Fig. l), seem to be dispensable for protein 
folding and catalysis. 
Although residues 36-44 of the (x2 helix in the GST 
Pl-1-ligand complex contact the hexyl moiety of the 
bound ligand S-hexyl glutathione, there are pronounced 
differences in the sequence of this potential LRS between 
GST isozymes. For instance, it contains a two residue 
insertion for the human isozyme compared to the porcine 
enzyme, with no significant effect on activity or stability 
[16]. Moreover, the M-class GST isozymes resemble the P- 
class isozymes in subunit fold and association, but this 
region is markedly divergent, with no helical character in 
the reported structure of the M-class isozyme [18]. Thus, 
modifications in this region may alter substrate recognition 
without disruption of folding or catalysis. 
Two residues in the a2 segment are also involved in GSH 
recognition. Trp38 acts as a hydrogen bond donor to the 
Gly residue of GSH and Lys44 forms an important salt 
bridge with the terminal carboxylate of this substrate. 
Residues downstream of the ~‘2 segment neighbor the 
GSH binding area. From all the structural data available, 
we concluded that alterations to the (-wZ segment from 
Glu36 to Leu43 should affect ligand binding, with minimal 
disruption of enzymatic activity, as desired for an LRS. 
The H-site carboxyl terminus (residues 204-210) in the 
M and P classes is also a potential LRS. It is a solvent- 
exposed loop, and residues 203-204 neighbor the hexyl 
moiety of the bound ligand in the crystal structure [ 161, 
although they are not involved in GSH recognition. This 
segment does not interact with other protein 
subdomains, and thus its integrity should not be 
important to the overall protein fold. Both the a2 LRS 
candidate and the carboxy-terminal segment have above 
average crystallographic temperature factors, suggesting 
that these regions are somewhat flexible. This may allow 
inducible formation of complementarity with diverse 
substrates. The flexibility further suggests that these 
segments do not make critical contributions to the 
overall stability of the protein. 
Properties of the novel proteins 
Using PCR mutagenesis, we created three glubody 
libraries by randomizing amino acids within regions 36-43 
and/or 204-210, or by inserting five random amino acids 
followed by Pro between Asn206 and Gly207. These 
LRS-mutagenized libraries contained between 1 x lo6 and 
5 x lo6 recombinants. Sequencing 20 random clones from 
each library demonstrated the fidelity of the mutagenesis 
procedure; greater than 90 %  of the clones had random- 
ized sequence in the correct region without changing the 
register of the reading frame. A minimum of 20 randomly 
picked clones from each of the three glubody libraries 
were screened for immunoreactivity by Western blot 
analysis to verify that the plasmid constructions could 
yield adequate quantities of protein for analysis. Over 
75 %  showed significant amounts of recombinant protein 
from bacterial extracts as visualized with antibodies 
against both GST Pl-1 and a peptide fragment of c-myc, 
which served as a carboxy-terminal immunological tag 
[Zl]. This appended peptide tag had a measurable effect 
on compound inhibition of the recombinant parental 
enzyme compared to its native form; accordingly, the 
glubody properties described below are always compared 
to those of the recombinant parental protein rather than 
the native GST Pl-1. 
Randomly picked clones producing substantial amounts of 
glubody protein were tested individually for GST activity 
as measured by their ability to conjugate the standard 
small chromogenic substrate, l-chloro-2,4 dinitrobenzene 
(CDNB) to GSH, which causes a change in absorbance at 
340 nm. The mutated proteins varied considerably in their 
enzymatic properties. Of 40 randomly picked glubodies 
from the three libraries, 21 retained measurable enzyme 
activity (i.e. at least 3 to 5-fold over background). Several 
additional clones had low activity, while the activities of 
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the rest were undetectable over background. Sequencing 
of all 40 clones showed that they contained randomized 
sequence in the expected region. Thus, many modifica- 
tions of the chosen LRS segments of GST Pl-1 do not 
abolish binding of either CDNB or glutathione in the 
active site. 
Of the 21 clones that retained CDNB conjugation 
activity, 17 express a sufficient amount of recombinant 
protein to be detected by immunoblotting using anti- 
GST Pl-1 or anti-c-myc monoclonal antibodies. The 17 
expressors were characterized by a preliminary screen for 
inhibition of catalytic activity by a panel of 20 
compounds, providing an initial inhibition profile. Five of 
the glubody clones were subsequently examined in much 
greater detail, beginning with the determination of 
specific activities relative to the parental enzymes by 
using CDNB assays. Aliquots from clone extracts were 
evaluated for protein content by screening dot blots with 
labeled antibodies to GST. Whereas the recombinant 
enzyme had activity equivalent to the native enzyme, the 
glubodies exhibited an =17-fold range in specific activity 
(Table 1). To test for activity from potentially contam- 
inating bacterial proteins in the cell extracts, one clone 
was grown in larger quantities, purified by S-hexyl 
glutathione affinity chromatography [Z?], and retested, 
with no significant change in specific activity or in the 
other properties examined below. 
To further characterize alterations in binding specificity, 
the extracts were assayed in the presence of potential 
inhibitors from a variety of chemical classes. The potency 
of some of these inhibitors had previously been found to 
vary significantly among the major natural GST isoforms 
[23]. Most inhibitors have moderate affinity for the natural 
Pl-1 enzyme, and only 1 out of the 18 compounds selec- 
ted for screening did not bind significantly to Pl-I. The 
recombinant parental PI-1 exhibits lower affinity for the 
Table 1 
Specificity of GST Pl-1 and glubodies. 
Enzyme rnhrbrtron . (-log IC,,) 
# Compound name Pl-1 recomb Pl Gb/204-19 Gb1204-21 Gb1204-23 Gb/206L-8 Gb1206L-12 
1 Fluorescein isothiocyanate, isomer 1 400 zk 200 NJ. N.I. N.I. N.I. NJ. 210f30 
2 9-Phenyl-2,3,7-trihydroxy-6-fluorone 11 .o f 3. 80 k 30.0 N.I. 140f30 N.I. 166+56 90f40 
3 4-(6-Hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid 400 k 150 N.I. 350 f 200 N.I. 310+ 120 NJ. NJ. 
4 6-Hydroxy-3-oxo-3H-xanthene-9-propionic acid 45 f 5.0 120f50 260+140 1401t50 45.8 f 5.0 N.I. 410 + 230 
5 1,2,3,4-Tetrafluoro-5,8-dihydroxy- 
anthraquinone, 99 o/o 16.3 f 0.7 300 f 170 N.I. 7.9 f 2.2 29.0f18.0 77.9k4.4 8.0 f 1 .O 
6 Cephaloglycin 20flO N.I. N.I. 400 f 70 300 f 35 N.I. N.I. 
7 Cephapirin sodium salt 42f9 120 f 30 N.I. 87f6 N.I. NJ. 300f 100 
8 Cephalothin sodium salt 20.0 f 6 70 k 20 470f 130 44+8 210f50 490 f 250 N.I. 
9 Cephaloridine 30+10 60.0flO 480f140 42.4+5.8 340f130 390+170 160f60 
10 Cefoperazone sodium salt, 90 O/o 39 Lk 1 150f50 N.I. 73.3 f 14.7 330 + 73 326f12 260f100 
1 1 y-Glutamyl-S-hexyl cysteinyl-glycine 9.6 + 0.6 300 f 150 N.I. 190f40 115f54 N.I. 240 f 35 
12 y-Glutamyl-S-2-methylnapthalene cysteinyl-glycine 1 1 .O + 2.0 50flO N.I. 135f30 67.1 f6.9 220+100 130f50 
13 y-Glutamyl-S-butyl cysteinyl-glycine 80flO 300 f 100 N.I. 290 zk 75 200flOO 360+60 110+6 
14 y-Glutamyl-S-benzyl cysteinyl-glycine 3.0 f 3.0 23.0 2~ 8. N.I. 300+200 150f74 140f30 140f50 
15 2-Mandelamido-4nitrophenol 200f 100 N.I. N.I. 400f 100 310+ 110 N.I. NJ. 
16 3-Nitro-5,6-benzo-2Hchromene <l 12.0 f 7.0 60 k 20 10.9 + 2.1 75.1 f 3.6 16.0 + 3.0 20.0 f 3.0 
17 1 -Benzene sulfonamideoxime-naphthaquim-4-one 19 f 2.0 lOOf N.I. 79 f 22.0 64.1 f 8.8 N.I. 30.0 + 20.0 
18 3-Cyano-5-pentyl-2,3-dihydro-pyridine-2-thione N.I. N.I. N.I. N.I. NJ. 140 f 50 N.I. 
Specific activity (PM min-’ mg-‘) 57 52 21 3 8 10 16 
The inhibitory potency of 18 compounds for native GST Pl-1 , least three determinations. Specific activities of glubodies were 
dimerized recombinant enzyme (recomb Pl) and five catalytically active calculated based on normalization of protein levels assayed by 
glubodies (Gb) are quantified as -log IC,, (FM) calculated from a immunological methods. N.I. = no measurable inhibition. 
series of five-fold dilutions. Standard deviations (SD) are based on at 
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Figure 2 
Glubodies have novel profiles of inhibition by a panel of small 
molecules. Black boxes represent the most potent compounds and 
white boxes represent no detectable inhibition (numerical data in 
Table 1). Pl-1 is the parental native enzyme; recomb Pl is the 
recombinant enzyme expressed with a carboxy-terminal c-myc tag. 
The gray scale thresholds of IC,, are, from black to white: < 10 p,M; 
1 O-l 00 PM; 100-300 PM; 300-500 p,M; no measurable inhibition. 
compounds compared to the wild type, apparently due to 
the c-myc peptide tail, but parallels its inhibition patterns 
overall. The H-site is in part formed by the carboxyl 
terminus and proximal alterations in amino acid sequence 
are thus likely to influence inhibitor binding patterns of 
the tagged protein. The variation of the inhibition profiles 
of the recombinant Pl-1 compared to the natural form is, 
however, no more extensive than that between the natural 
variants, even using a set of inhibitors known to differ in 
potency for the various natural GSTs. 
The IC,, data for the five glubodies examined in detail 
(Table 1) show that some of the novel proteins have 
markedly different inhibitor profiles using this panel of 
compounds. The qualitative differences are easily seen by 
plotting the data with a gray scale representing the 
inhibition potencies (Fig. 2). In general, the glubodies 
have a wide range of reactivity with the panel of inhibitor 
compounds. Some glubodies, such as Gb/‘204-21 and 
Gb/204-23, recognize more compounds than the recombi- 
nant parent, demonstrating that this approach can generate 
enzymes with broader specificities. By contrast, Gb/206L-8 
has a more restricted range of inhibitor susceptibility; this 
change is accompanied, however, by novel recognition of 
compound #18, which does not bind to any of the other 
proteins. An even more extreme change in specificity is 
seen in Gb/204-19, which is not strongly inhibited by any 
of the GSH conjugates tested, despite the fact that this 
enzyme has high specific activity using the standard 
CDNB substrate. This glubody is particularly interesting 
as it included a shift in reading frame, resulting in 
expression of a protein with an extreme carboxy-terminal 
alteration (Table 2). This frame shift extends the carboxyl 
terminus and clearly affects the ability of the protein to 
recognize ligands, although it exerts a much less 
pronounced effect on the catalytic activity (Table 1). 
Unlike Gb/204-19, gluthathione S-transferases of the A 
and M classes have extended carboxy termini that do not 
appear to increase their substrate specificities. 
The correlations of -log IC,, values determined for each 
glubody against all compounds were calculated in a pair- 
wise fashion. The degree of correlation was assessed by 
computing correlation coefficients (S-Plus advanced data 
analysis software, StatSci, Seattle, WA). For all pairs of the 
natural human isozymes examined, as well as with the 
recombinant Pl-1, the natural isozymes appear highly 
correlated (not shown). The observed variability in the 
glubodies is summarized in Table 3 by calculating the 
pairwise correlation coefficients of the affinities (ex- 
pressed as -log IC,,) for the compounds shown in Table 1. 
The wild type and recombinant parental enzyme show 
Table 2 
Sequences of randomized regions of glubodies. 
Clone Amino acid 204-210 
Parental INGNGKQ 
Gb/204-21 NCARCNT 
Gbl204-23 TGYGCVL 
Gb/204-19 QVWGSGGRPQNKNSSQKRL 
Clone N206 - loop insertion - G207 
Gb/206L-8 VDLPCE 
Gb/206L-12 SNVCLP 
Clone Amino acid 36-43 
Parental ETWQEGSL 
Gb/36-1 FRRLLPSL 
Gb136-2 WRVVEILV 
Sequence position refers to the wild type Pl monomer. The 
underlined P refers to an added proline residue after the insertion of 
five random amino acids. This proline residue is not present in the 
native enzyme. Sequences from the Gb136 library represent clones 
that underwent some preliminary testing in enzyme-inhibition assays. 
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Table 3 
Correlations in enzyme-inhibition properties. 
Pl-1 rPl-1 Gb1204-19 Gb/204-21 Gbl204-23 Gb/206L-8 Gb/206L-12 
Pl-1 1 .ooo 
rPl-1 0.836 1 .ooo 
Gb/204-19 0.291 0.356 1.000 
Gb1204-21 0.749 0.720 0.307 1 .ooo 
Gb1204-23 0.503 0.390 0.314 0.547 1 .ooo 
Gb/206L-8 0.470 0.541 0.254 0.478 0.175 1 .ooo 
Gb/206L-12 0.592 0.591 0.025 0.647 0.412 0.502 1 .ooo 
Glubody variants of GST Pl-1 with high sequence identity range in compared to the recombinant parental protein or to each other. Pairwise 
character from similar to widely divergent in binding properties correlation coefficients calculated from the data in Table 1 are shown. 
the highest correlation, indicating the highest degree of 
similarity in affinity patterns among all the proteins 
compared. Among the novel glubodies, pairs of effectively 
uncorrelated patterns of affinity can be seen, such as for 
Gb/206L-8 and Gb/204-23, or Gb/206L-12 and Gb/204-19. 
Evidently, LRS mutagenesis generates glubodies that 
vary widely in sensitivity to inhibitors, used as a measure 
of binding affinities for individual compounds. No 
correlation is apparent between binding specificity and 
specific activity against CDNB, or between binding 
properties and mutation type, at least within an LRS. 
disrupt its folding, as we have shown here using GST and 
the sensitive assay of catalytic activity. 
Enzyme-inhibition data were also collected for individual 
members of the Gb/36 library, in which the other candidate 
LRS, from Glu36 to Leu43, was mutagenized. Two clones 
(sequences in Table 2) seem to be as different from each 
other, and from the other glubodies, as any of the other 
pairs. Similarly, spot checking of several additional clones 
from the carboxy-terminal libraries suggests that the clones 
examined in detail and documented in Table 1 do not 
exhaust the diversity of this library; rather, every clone 
examined seems to be significantly different from most of 
the others. 
Glubody variants of GST Pl-1 range in character from 
similar to widely divergent in ligand binding properties 
compared to the parental protein with which they share 
nearly 97% sequence identity (Table 2). It is interesting to 
note that glubody variants with totally different variable 
regions can have either similar or divergent binding 
properties. Thus, glubodies provide a rich source of data 
for exploring the relationship between protein structure 
and function, and the techniques described here provide 
tools for engineering proteins with particular desirable 
properties [24]. 
Implications 
The defining features of an LRS found in GST are 
discernable in many proteins in the crystallographic 
database. The salient elements are a solvent-exposed 
linear segment of -8 residues that is adjacent to the 
substrate binding site, and low relevance of the segment 
to the overall structural integrity of the protein as 
indicated by few non-local contacts and higher than 
average flexibility. Flexibility can be assessed by 
crystallographic temperature factors or mobility in 
molecular dynamics simulations. In both the a2 and 
carboxy-terminal LRS, some residues are in direct contact 
with the bound ligand on one side and are solvent 
exposed on the other side. In neither case do the mutated 
regions have direct interactions with other regions of the 
protein, and the mutations are thus not likely to affect the 
stability of the protein. Mutagenizing regions with 
significant flexibility within a protein does not severely 
Other mutagenesis studies have been carried out to alter 
the ligand-binding properties of GST. Gulick and Fahl 
[12] mutated several regions of a rat 2-2 GST A-class 
enzyme to search for proteins better able to detoxify an 
electrophilic toxin, mechlorethamine. The successful 
clones were mutated primarily in residues 9-11, 
supporting our identification of residues 8-15 as a likely 
target for altering substrate specificity. A bacteriophage 
library has recently been prepared [13] that displays an A- 
class GST that had previously had selected hydrophobic 
amino acids mutagenized. Using a panning technique, 
phage were selected for the ability to bind a set of 
glutathione derivatives, and thus it was not possible to 
determine how many of the unselected clones were stably 
folded but had altered substrate specificity. The selected 
GST mutants had drastic reductions in specific activity for 
CDNB, generally one to three orders of magnitude lower 
than the least active glubody described here. 
Nonetheless, the success of the mutagenized GST 
panning experiments supports the possibility that the 
LRS mutagenesis strategy outlined here could be applied 
to assay properties of the novel binding sites by non- 
enzymatic means, such as competitive ligand binding. 
Further support is provided by studies on phage 
displayed cytochrome b-562, containing mutations in the 
solvent exposed loops that are free of non-local 
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interactions and would not be expected to affect folding 
[ZS]. Panning against a specific antigen yielded clones 
with consensus-sequence motifs within the randomized 
regions. As noted above, however, the breadth of novelty 
in binding properties is not addressed by these methods. 
A different approach to improving the utility of glubody 
libraries is to replace random mutagenesis with more 
directed methods, for example using pre-made nucleotide 
triplets to create the randomized regions [26]. In this way, 
libraries can be created to explore specific structure-activity 
hypotheses (e.g. perhaps replacing all the residues in an 
LRS with hydrophobic amino acids). Such an approach 
allows smaller libraries to be synthesized that effectively 
sample the diversity of the full combinatorial library [27]. 
Aside from practical utility in creating new diagnostics and 
catalysts, the ability to create homologous proteins that 
differ widely in ligand recognition should be useful in 
uncovering the cryptic similarities among binding sites of 
unrelated proteins. These similarities have recently been 
documented by examining correlations in cross-reactivity of 
various proteins to drugs and other small molecules [24]. 
Significance 
We have identified structurally permissive segments of 
GST and subjected them to mutagenesis, generating enzy- 
mes with altered ligand-binding properties. These results 
demonstrate that a non-antibody framework can be used 
to create large libraries of proteins with a wide range of 
binding specificities for small organic molecules. Modifying 
the deep binding cleft of GST, which has evolved to 
accommodate small molecules, may facilitate the develop 
ment of diagnostic reagents for such molecules as well as 
the discovery of novel catalysts, perhaps including new 
enzymes capable of metabolizing environmental toxins. 
The manner in which the glubodies were engineered, 
using intensive randomization of an LRS, opens the 
Table 4 
possibility that similar libraries can be generated from 
many other proteins and enzymes that contain amino- 
acid segments with the characteristics of an LRS. These 
varied panels of binding proteins should prove useful for 
correlating structural and functional features relevant to 
ligand binding in general. In contrast, most previous 
studies of mutant enzymes have emphasized structural 
features related to catalytic function [281. Generalities 
such as preferential use of particular amino acids in 
binding sites, which have been noted in existing proteins 
1291, can now be tested on a broader scale, thus con- 
tributing to a deeper understanding of protein-ligand 
recognition processes and to more efficient drug design. 
Materials and methods 
Genetic engineering 
Three glubody libraries (Gb/P36, Gb/P204 and Gb1206L) were 
prepared by similar procedures, using the primers defined in Table 4 to 
target PCR mutagenesis to particular regions. The GST Pl expression 
vector (pKXHP1) [30] has had an internal Sfil site at nucleotide position 
573-585 removed by overlap PCR mutagenesis, using primers L569 
and R594. A G-to-A substitution at position 582 removed the Sf/l site 
while leaving the amino acid sequence unchanged. 
Randomized glubody libraries were constructed essentially following the 
method for antibodies of Barbas et al. [31 I. GblP36 contains an eight 
amino acid randomized region beginning at position 36 in the parental 
amino acid sequence. GblP204 has seven randomized residues 
beginning at position 204, very near the carboxyl terminus. Gb/206L 
contains an insertion of five randomized amino acids followed by a 
constant Pro residue between N206 and G207. All were made 
analogously using the appropriate primers. For the carboxy-terminal 
mutants, only one PCR reaction was used; for the internal fragment, two 
sequential reactions were used to simplify primer synthesis. 
For randomization of amino acids corresponding to position 36-43 
(ETWQEGSL), two primary amplifications were performed. Reaction 1 
contained 10 pmol each of primers Lext and P36Rint, Perkin-Elmer Taq 
polymerase buffer with MgCI, added to 2 mM, 10 ng of template 
pKXHP1, all four dNTP’s at 250 FM each and 2.5 units of Taq 
polymerase in a final volume of 50 ~1. Reaction 2 was identical to 
reaction 1 except that it contained the primers P36LintR and R210. 
Using an Omnigene thermal cycler, the reaction mixes were put 
PCR primers for glubody construction. 
Primer Sequence (5’ + 3’) 
L569 TCAAGGCCTTCCTAGCCTCCCCTGA 
R594 TCAGGGGAGGCTAGGAGGCCTTGA 
Lext CATGCCATGACTCGCGGCCCAGCCGGCCATGGCATGCCTCCATACACAGTTGTTTA 
P36Rint CACGGTCACCACCTCCTCCTTCCA 
P36LintR AAGGAGGAGGTGGTGACCGTGNNSNNSNNSNNSNNSNNSNNSNNSAAAGCCTCCTGCCTATACGGG 
R210 CCAGCATTCTGCGGCCGCCTGTTTCCCGTTGCCATTGATGG 
R210 CCAGCATTCTGCGGCCGCSNNSNNSNNSNNSNNSNNSNNGGGGAGGTTCACGTACTCAGG 
R206Loop CCAGCATTCTGCGGCCGCCTGTTTCCCGTTGCCCGGGSNNSNNSNNSNNSNNSNNATTGATGGGGAGGTTCAC 
The number in the primer name refers to the nucleotide position of 5’ (where appropriate). N = A, C, G, or T (equimolar); S = G or C 
nucleotide of the primer within the sequence of human GST Pl-1 (equimolar). 
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through 25 cycles of denaturation (94 ‘C, 1 min), annealing (65 “C, 1 
min), and extension (72 “C, 1 min) followed by a final cycle of extension 
(72 “C, 10 min). The reaction products were gel purified, subjected to 
overlap extension and assembled as follows: 100 ng of purified 
product from reaction 1 was combined with 100 ng of purified product 
from reaction 2 and added to a PCR reaction mix containing Taq 
polymerase buffer with MgCI, added to 2 mM,  dNTP’s at 250 (LM and 
2.5 units of Taq polymerase in a final volume of 50 pl. This assembly 
mix was then taken through seven rounds of denaturation (94 “C, 1 
min) and annealing (65 “C, 2.5 min) after which 10 pmols each of 
primers Lext and R210 were added and the PCR amplification 
continued for 25 cycles as above. The resulting product is a GST Pl 
mutant with a randomized loop domain and is designated Gb136 
cDNA. This fragment was gel purified, digested with Sf/l and Nod, and 
gel purified once again. 
For randomization of amino acids 204-210 (INGNGKQ), a primary 
PCR reaction was performed as described above except that 10 pmol 
of the primer R21 OR was used to replace R210 in the amplification. 
PCR products were purified and digested as above. The mutant cDNA 
generated from this reaction was designated Gb1204 cDNA. The loop 
insertion library was made in a similar manner using 10 pmol of the 
primer R206Loop and the cDNA from this library designated Gb1206L. 
Digested cDNA (1 pg) from each library was ligated to 1 p,g SfillNofl- 
restricted pHEN-1 phagemid vector 1211 in a standard ligation 
reaction, and electrotransformed into the non-suppressor E. co/i strain 
HB2151 by established procedures 131. Individual clones were 
induced to produce protein as described below. 
Preparation of bacterial extracts 
Overnight cultures from individual clones grown in LB medium with 
100 pg ml-l of ampicil l in and 1 %  glucose were diluted into LB 
supplemented with antibiotic and 0.1 %  glucose and incubated at 
37 “C with shaking until the culture reached an OD,,, of 0.6-0.9. 
IPTG was added to a final concentration of 1 m M  and the culture 
grown at 30 “C overnight with shaking. Bacterial cultures were 
harvested and centrifuged at 7000 x g in a Sorvall SS-34 rotor for 5 
min at 4 “C. Cell pellets were frozen and thawed twice using dry 
ice/ethanol and a water bath at 37 “C and resuspended in one tenth 
the original culture volume of lysis buffer (10 m M  Tris-HCI, pH 7.6, 50 
m M  EDTA, 15 %  glucose and lysozyme (Sigma) at 1 mg ml-‘). PMSF 
was added to a final concentration of 250 (LM and the solution allowed 
to sit on ice for 1 h. The suspension was sonicated on ice with a 
Branson Sonifier 450 at 50 %  duty cycle and 6 output setting for a 
total of 60 pulses. Samples were centrifuged for 30 min. at 25 000 x g 
in a Sorvall SS-34 rotor at 4 “C. The supernatant was collected and 
stored at 4 “C. 
Enzymatic activity determination 
GST activity was measured by the ability to conjugate CDNB to GSH 
(reduced glutathione). IC,, values were measured in a standard 
conjugation assay which contains 1 m M  GSH and 1 m M  CDNB in 
200 m M  sodium phosphate, pH 6.6 1151. Compounds were assayed 
for their inhibitory activity at 250, 50, 10, 2 and 0.4 FM. Conjugation of 
GSH and CDNB was followed for 5 min at 30 “C by measuring the 
absorbance increase at 340 nm in a thermostated microplate reader 
(Molecular Devices, Menlo Park, CA). For IC,, determinations, 
individual glubody extracts were normalized for constant activity i.e. to 
produce absorbance readings at 340 nm of 40-50 mOD by addition 
of E. co/i extract from a pHEN-1 transformant to equalize the amount of 
bacterial protein present in each assay. 
Specific activity determination 
auantitation of glubody protein was accomplished by dot-blotting and 
subsequent scanning using a UMAX scanner (Fremont, CA) of serial 
dilutions of glubody extracts onto nitrocellulose strips where detection 
was either with polyclonal anti-GST Pl-1 antisera or anti-c-myc 
monoclonal antibody. Specific activities were calculated based on 
amount of enzyme activity per mg of protein using the purified native 
GST Pl-1 enzyme as the standard. 
Reagents 
Compounds 1 l-l 4 were synthesized at Terrapin Technologies, 
Incorporated (South San Francisco, CA). All other chemicals were 
reagent grade and purchased from either Aldrich Chemical Company 
(Milwaukee, WI) or Sigma Chemical Company (St. Louis, MO). Taq 
polymerase was from Perkin-Elmer Cetus (Norwalk, CT). Restriction 
enzymes and T4 DNA Ligase were from New England Biolabs 
(Beverly, MA). dNTP’s were from Pharmacia Biotech (Alameda, CA). 
Anti-c-myc monoclonal antibody 9ElO was purchased from Santa 
Cruz Biotechnology (Santa Cruz, CA). The PCR primers were 
prepared on a Biosearch 8750 DNA synthesizer using reagents from 
Prime Synthesis (Astin, PA). pHEN-1 phagemid vector was generously 
provided by Dr Jorg Berg of University of California at San Francisco. 
The GST Pl-1 vector, pKXHP1, was the generous gift of Dr Bengt 
Mannervik, University of Uppsala, Sweden. 
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